GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

tagitanlimab   Click here for help

GtoPdb Ligand ID: 13795

Synonyms: A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167
Approved drug Immunopharmacology Ligand
tagitanlimab is an approved drug
Compound class: Antibody
Comment: Tagitanlimab (KL-A167) is a humanized anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody [1]. It is designed to block the inhibitory PD-1/PD-L1 immune checkpoint and restore anti-tumour immunity.
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes. China NMPA (2024)
International Nonproprietary Names Click here for help
INN number INN
11843 tagitanlimab
Synonyms Click here for help
A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1206
Other databases
GtoPdb PubChem SID 507750428
Search PubMed clinical trials tagitanlimab
Search PubMed titles tagitanlimab
Search PubMed titles/abstracts tagitanlimab